ARTICLE | Company News
FDA approves DepoCyt re-launch
March 2, 2001 8:00 AM UTC
SkyePharma (SKYE; LSE:SKP) and Chiron (CHIR) received FDA approval to re-launch DepoCyt cytarabine liposome injection for the treatment of lymphomatous meningitis. The companies withdrew the treatment...